Literature DB >> 11598399

Management of hyperinsulinemia with diazoxide in an elderly hemodialysis patient.

A J Shaer1.   

Abstract

An elderly, nondiabetic, chronic hemodialysis patient is described here who had profound hypoglycemia for a myriad of reasons including renal failure, malnutrition, and quinine use. Furthermore, by biochemical parameters the patient had hyperinsulinemia, which was consistent with the diagnosis of an insulinoma. However, a tumor was not identified by noninvasive radiologic imaging as is often the case and the patient was not a candidate for surgical exploration. Diazoxide at a dose of 225 mg/day was used to successfully manage this patient's hypoglycemia. Previous experience with the use of diazoxide for hyperinsulinism in the hemodialysis population is limited and this case is the second report of its use for this purpose. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598399     DOI: 10.1159/000046095

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  The use of diazoxide in the management of spontaneous hypoglycemia in patients with ESRD.

Authors:  Bayan Mesmar; Megan Kristan; Medha Satyarengga; Elizabeth M Lamos; Rana Malek; Kashif M Munir
Journal:  CEN Case Rep       Date:  2020-04-09

2.  Successful treatment of adult-onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis.

Authors:  Rina Kato; Akihiro Nishimura; Kimio Matsumura; Shota Kikuno; Kaoru Nagasawa; Yasumichi Mori
Journal:  Clin Case Rep       Date:  2020-11-11

3.  Insulinoma.

Authors:  Andrew R Burns; Alan P B Dackiw
Journal:  Curr Treat Options Oncol       Date:  2003-08

4.  Calcium Stimulation Test for Insulinoma Localization in an End-stage Renal Disease Patient on Diazoxide.

Authors:  Stephanie Kim; Miles Conrad; Eunice Chuang; Larry Cai; Umesh Masharani; Elizabeth J Murphy
Journal:  J Endocr Soc       Date:  2020-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.